Biotechnology

Techseriesinsight > Blog > News > Biotechnology

August 5, 2025
PRNewswire
Biotechnology, News

Trailblazing Female Founder Award Presented to Evofem CEO

Evofem Biosciences, Inc. (OTCID: EVFM) is proud to announce that its CEO, Saundra Pelletier, will be honored with the Trailblazing Female Founders Award at the 2025 STIMULATE Conference, the premier U.S. sexual wellness industry event....

lab image, Raytone-Biotech-Announces-First-Patient

August 4, 2025
PRNewswire
Biotechnology, Healthcare, News

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of RTP-008 during Q2 2025....

microbacteria image, Turbine-to-Simulate-Hard-to-Treat-Cancer

August 4, 2025
PRNewswire
Artificial Intelligence, Biotechnology, Healthcare, News

Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD

Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations...

two person handshaking which shows partnership, Atombeat-and-BioDuro-Announce-Strategic.jpg

August 1, 2025
PRNewswire
Artificial Intelligence, Biotechnology, News

New Platform Speeds Peptide Drug Discovery with AI & Synthesis

On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an AI powered platform for...

doctor in lab, Energenesis-Biomedical-Announces-Positive

August 1, 2025
PRNewswire
Biotechnology, Healthcare, News

Energenesis Announces Successful Phase I Trial for Parkinson’s Therapy

Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company focused on cellular energy restoration therapeutics, today announced the successful completion of its Phase I clinical trial for ENERGI-F705PD,...

July 30, 2025
Business Wire
Biotechnology, Healthcare, News

NeoGenomics Expands PanTracer Portfolio with LBx Launch

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling (CGP) test,...

July 30, 2025
PRNewswire
Biotechnology, Healthcare, News

MAGENTIQ‑COLO AI Platform Receives Series A to Drive Innovation

MAGENTIQ EYE LTD., a leading innovator in AI-powered gastroenterology decision-support software, today announced the successful completion of its Series A funding round. MAGENTIQ EYE’s FDA- and CE-approved software, MAGENTIQ-COLO™, enhances polyp...

July 29, 2025
PRNewswire
Artificial Intelligence, Biotechnology, Healthcare, News

Simulations Plus and IMB Validate AIDD Module in ADMET Predictor

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that experimental...

July 29, 2025
PRNewswire
Biotechnology, News

Hope in New Alzheimer’s Blood Test

TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a strategic collaboration with T-NeuroDx, a pioneering diagnostics company dedicated to developing innovative solutions for detecting neurodegenerative diseases,...

July 28, 2025
PRNewswire
Artificial Intelligence, Biotechnology, News

BATMAN brings TCR therapy out of the shadows

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment....